Sompo Asset Management Co., Ltd.
Source: SEC Form 13F · as of Mar 2026Sompo Asset Management Co., Ltd. holds 18 biotech & pharma companies tracked by BioSniper, totaling $30.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$30.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 32,039 | $7.8M |
| MRKMerck & Co., Inc. | 64,270 | $7.7M |
| LLYELI LILLY & Co | 3,210 | $3.0M |
| BMYBRISTOL MYERS SQUIBB CO | 44,554 | $2.7M |
| BIIBBIOGEN INC. | 8,776 | $1.6M |
| ABBVAbbVie Inc. | 5,000 | $1.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,800 | $758K |
| PMPhilip Morris International Inc | 4,560 | $754K |
| GILDGILEAD SCIENCES, INC. | 4,960 | $691K |
| ABTABBOTT LABORATORIES | 6,320 | $649K |
| AMGNAMGEN INC | 1,830 | $644K |
| GMOptec International, Inc. | 8,370 | $624K |
| MCKMcKesson Corporation | 650 | $562K |
| ZTSZoetis Inc. | 4,590 | $543K |
| PFEPFIZER INC | 18,800 | $528K |
| CAHCardinal Health Inc. | 2,090 | $442K |
| ELVElevance Health Inc. | 1,250 | $366K |
| ZBHZimmer Biomet Holdings Inc. | 3,130 | $283K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.